Preoperative FDG PET/CT in breast cancer patients: where are we going?
EUR J NUCL MED MOL I
39
1667 1669
4,991
GIORDANO A., FERRARI G., RADICE D., RANDI G., BISANTI L., SOLARI A., ON BEHALF OF THE POSMOS STUDY
Health-related quality of life and depressive symptoms in significant others of people with multiple sclerosis: a community study.
EUR J NEUROL
19
847 - 854
GIORGI ROSSI P., SIDERI M., CAROZZI F. M., VOCATURO A., BUONAGURO F. M., TORNESELLO M. L., BURRONI E., MARIANI L., BOVERI S., ZAFFINA L. M., CHINI F., THE HPV PREVALENCE ITALIAN WORKING GROUP
HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies.
INF AGENTS CAN
GIORGI ROSSO P., RONCO G., CONFORTINI M., MACCALLINI V., NALDONI C., SEGNAN N., SIDERI M., ZAPPA M., ZORZI M., CALVIA M., GIORGI ROSSO P.
[Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening].
EPIDEMIOL PREV
GIORGIO M., BERRY A., BERNIAKOVICH I., POLETAEVA I., TRINEI M., STENDARDO M., HAGOPIAN K., RAMSEY J. J., CORTOPASSI G., MIGLIACCIO E., NOTZLI S., AMREIN I., LIPP H. P, CIRULLI F., PELICCI P. G.
The p66(Shc) knocked out mice are short lived under natural condition.
AGING CELL
GIOVANNETTI E., TOFFALORIO F., DE PAS T., PETERS G. J.
Pharmacogenetics of conventional chemotherapy in non-small-cell lung cancer: a changing landscape?
PHARMACOGENOMICS
13
1073 1086
3,974
GJERDE J., GANDINI S., GUERRIERI GONZAGA A., HAUGAN MOI L. L, ARISTARCO V., MELLGREN G., DE CENSI A., LIEN E. A
Tissue distribution of 4-hydroxy-N-desmethyltamoxifen and tamoxifen-N-oxide.
BREAST CANCER RES TR
134
693 - 700
4,431
GODDI A., BONARDI M., ALESSI S.
Breast elastography: A literature review.
J ULTRAS MED
15
192 - 198
1,245
GOLDHIRSCH A., GELBER R. D.
Breast cancer: Anastrozole and fulvestrant-combination to unlock efficacy.
NAT REV CLIN ONCOL
9
556 - 557
11,963
GORI S., GRECO M. T, CATANIA C. M., COLOMBO C., APOLONE G., ZAGONEL V., AIOM GROUP FOR THE INFORMED CONSENT IN MEDICAL ONCOLOGY
A new informed consent form model for cancer patients: Preliminary results of a prospective study by the Italian Association of Medical Oncology (AIOM).
PATIENT EDUC COUNS
87
243 - 249
2,305
GRANA C. M., CHINOL M., DE CICCO C., BARTOLOMEI M., CREMONESI M., BODEI L., ROCCA P. A., PACIFICI M., TIBERINI S., BAIO S. M., BROGGI G., SEVERI S., PAGANELLI G.
Eleven-Year Experience with the AvidinBiotin Pretargeting System in Glioblastoma: Toxicity, Efficacy and Survival
O NUCL MED J
4
14 - 20
0
GRUSZKA A. M, ALCALAY M.
Clinical and Biological Relevance of Gene Expression Profiling in Acute Myeloid Leukemia
Myeloid Leukemia – Clinical Diagnosis and Treatment
10
197 - 210
0
GRUSZKA A. M., MARTINELLI C., SPARACIO E., PELICCI P. G., DE MARCO A.
The concurrent use of N- and C-terminal antibodies anti-nucleophosmin 1 in immunofluorescence experiments allows for precise assessment of its subcellular localisation in acute myeloid leukaemia patients.
LEUKEMIA
26
159 - 162
9,561
GUIU S., MICHIELS S., ANDRE F., CORTES J., DENKERT C., DI LEO A., HENNESSY B. T., SORLIE T., SOTIRIOU C., TURNER N., VAN DE VIJVER M., VIALE G., LOI S., REIS-FILHO J. S.
Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement.
ANN ONCOL
23
HEIN R., MARANIAN M., et al.
Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC).
PLOS ONE
7
Rare variants in XRCC2 as breast cancer susceptibility alleles.
J MED GENET
HILBERS F. S., WIJNEN J. T., HOOGERBRUGGE N., OOSTERWIJK J. C., COLLEE M. J., PETERLONGO P., RADICE P., MANOUKIAN S., FEROCE I., CAPRA F., COUCH F. J., WANG X., GUIDUGLI L., OFFIT K., SHAH S., CAMPBELL I. G., THOMPSON E. R., JAMES P. A., TRAINER A. H., GRACIA J., BENITEZ J., VAN ASPEREN C. J., DEVILEE P.
276
IEO — Scientific Report 2012 — Ongoing Research 2013
7
36
11
49
26 - 26
e1 - e33
162 - 168
2997 3006
Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials.
ANN ONCOL
23
2843 2851
6,425
3,692
HUOBER J., GELBER S., GOLDHIRSCH A., COATES A. S., VIALE G., OHLSCHLEGEL C., PRICE K. N., GELBER R. D., REGAN M. M., THURLIMANN B.
HER2-negative (1+) breast cancer with unfavorable prognostic features: to FISH or not to FISH?
ANN ONCOL
23
1371 1372
6,425
0
IORFIDA M., DELLAPASQUA S., BAGNARDI V., CARDILLO A., ROTMENSZ N., MASTROPASQUA M. G., BOTTIGLIERI L., GOLDHIRSCH A., VIALE G., COLLEONI M. A.
Invasive lobular breast cancer: subtypes and outcome.
BREAST CANCER RES TR
133
713 - 723
4,431
0,651
IORFIDA M., MAIORANO E., ORVIETO E., MAISONNEUVE P., BOTTIGLIERI L., ROTMENSZ N., MONTAGNA E., DELLAPASQUA S., VERONESI P., GALIMBERTI V. E., LUINI A., GOLDHIRSCH A., COLLEONI M. A., VIALE G. JERECZEK B. A., BELTRAMO G., FARISELLI L., FODOR C., SANTORO L., VAVASSORI A., ZERINI D., GHERARDI F., ASCIONE C., BOSSI ZANETTI I., MAURO R., BREGANTIN A., BIANCHI L. C., DE COBELLI O., ORECCHIA R.
Robotic Image-Guided Stereotactic Radiotherapy, for Isolated Recurrent Primary, Lymph Node or Metastatic Prostate Cancer.
INT J RADIAT ONCOL
82
889 - 897
4,105
JERECZEK B. A., KAANDERS J. H., DUBRAY B., COTTRILL C., LEER J. W., ON BEHALF OF THE FACULTY OF THE TEACHING COURSE ON EVIDENCE-BASED RADIATION ONCOLOGY OF THE EUROPEAN SOCIETY OF THERAPEUTIC RADIOLOGY AND ONCOLOGY
Focal HIFU for prostate cancer.
LANCET ONCOL
13
e280 e281
22,589
JOHNSTON K., LEVY A. R, LORIGAN P., MAIO M., LEBBE C., MIDDLETON M., TESTORI A., BEDANE C., KONTO C., DUEYMES A., SBARIGIA U., VAN BAARDEWIJK M.
Economic impact of healthcare resource utilization patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: Results from a retrospective, longitudinal survey (MELODY study)
EUR J CANCER
48
2175 2182
5,536
KALOGERA E., DOWDY S. C., MARIANI A., ALETTI G., BAKKUM-GAMEZ J. N., CLIBY W. A.
Utility of closed suction pelvic drains at time of large bowel resection for ovarian cancer.
GYNECOL ONCOL
126
391 - 396
3,888
KARLSSON P., COLE B. F., CHUA B. H., PRICE K. N., LINDTNER J., COLLINS J. P., KOVACS A., THURLIMANN B., CRIVELLARI D., CASTIGLIONEGERTSCH M., FORBES J. F., GELBER R. D., GOLDHIRSCH A., GRUBER G., FOR THE INTERNATIONAL BREAST CANCER STUDY GROUP
Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report.
ANN ONCOL
23
2852 2858
6,425
KESSEL K. A, BOUGATF N., BOHN C., HABERMEHL D., OETZEL D., BENDL R., ENGELMANN U., ORECCHIA R., FOSSATI P., POTTER R., DOSANJH M., DEBUS J., COMBS S. E
Connection of European particle therapy centers and generation of a common particle database system within the European ULICE-framework.
RADIAT ONCOL
7
115 - 115
2,321
KLAENHAMMER T. R., KLEEREBEZEM M., KOPP M. V., RESCIGNO M.
The impact of probiotics and prebiotics on the immune system.
NAT REV IMMUNOL
12
728 - 734
33,287
KLIONSKY D. J., ABDALLA F. C., et al.
Guidelines for the use and interpretation of assays for monitoring autophagy.
AUTOPHAGY
8
445 - 544
7,453
KNEUBIL M. C, LOHSIRIWAT V., CURIGLIANO G., BROLLO J., BOTTERI E., ROTMENSZ N., MARTELLA S., MASTROPASQUA M. G., IERA M., COELHO M. B, INTRA M., ORECCHIA R., REY P., RIETJENS M., PETIT J. Y.
Risk of Locoregional Recurrence in Patients With False-Negative Frozen Section or Close Margins of Retroareolar Specimen in Nipple-Sparing Mastectomy
ANN SURG ONCOL
19
4117 4123
4,166
KRENGLI M., TERRONE C., JERECZEK B. A., BELDI' D., ORECCHIA R.
May intra-operative radiotherapy have a role in the treatment of prostate cancer?
CRIT REV ONCOL HEMAT
83
123 - 129
4,411
KRENN V., WEHENKEL A. M., LI X., SANTAGUIDA S., MUSACCHIO A.
Structural analysis reveals features of the spindle checkpoint kinase Bub1kinetochore subunit Knl1 interaction.
J CELL BIOL
196
451 - 467
10,264
KWIATKOWSKI N., DENG X., WANG J., TAN L., VILLA F., SANTAGUIDA S., HUANG H. C., MITCHISON T., MUSACCHIO A., GRAY N.
Selective aurora kinase inhibitors identified using a taxol-induced checkpoint sensitivity screen.
ACS CHEM BIOL
7
185 - 196
6,446
LAMBRECHTS D., TRUONG T., et al.
11q13 is a susceptibility locus for hormone receptor positive breast cancer.
HUM MUTAT
33
1123 - 1132
5,686
6,265
6,425
4,092
618 - 620
6,365
IEO — Scientific Report 2012 — Ongoing Research 2013
Publications
GILARDI L., DE CICCO C., PAGANELLI G.
277